Manufacturing & Packaging

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Plans are underway to build Scottish fill-finish center, renovate API facility in England

The solution is a combination of cold chain logistics, serialization compliance and distribution

With the deal, the China-based CDMO grows its US presence

Anticipated yearly production is 2 million units

Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices

CDMO's new South Korean facility to offer a range of production services

Acquisition of AcKnowledge RS also expands company's IVD expertise

Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs

Partnership enhances CBM’s manufacturing capabilities in C&GT space

Agreement allows CRO to grow its manufacturing services, including in the chemistry space

Marks the first step in two-phase facility expansion project

Center’s 89,000 square-foot expansion expected to double its capacity

Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies

Collaboration aims to prioritize best practices in fields of biopreservation and closed-system manufacturing, while improving children’s health

The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year

Investment features the construction of a high-throughput screening center

BFS technology deal expected to be finalized in Q1

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Site is located in the state of Gujarat, a major hub for pharma logistics

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing